Health Canada Issues MyoScience Inc. Approval for Its PCP 1.0 System

Published: Dec 16, 2011

REDWOOD CITY, CA (December 15th, 2011) – Health Canada has issued myoscience a medical device license for myoscience’s PCP 1.0 system for the temporary treatment of wrinkles and pain.

Myoscience’s patented technology precisely delivers cold energy to targeted nerves. The nerves revert to a hibernating state resulting in a temporary interruption of nerve signaling to sensory receptors or muscle tissue. The effects are immediate with nothing left behind in the patient.

The hand-held device is intended for use in the physician’s office and represents a breakthrough advance relative to older, larger cryotherapy devices. The myoscience design allows for use in superficial tissues that were previously unrealistic targets for older cryotherapy devices.

About myoscience. Myoscience is a privately held medical device company dedicated to developing innovative treatments in whichever fields it chooses to enter. Two generations of the myoscience device have already been cleared for use by the FDA.

Back to news